Cancer · 2009 · 10 citations · 4 references
MedicineOncologyEndocrine OncologyNeuroendocrine Tumor TherapyNeuroendocrine TumorsIodine-123 Metaiodobenzylguanidine ScintigraphyMetastatic Neuroendocrine TumorsNeuroendocrine Tumor PharmacologyNeuroendocrine Tumor Pharmacotherapy
The results from this phase 2 study indicated that the treatment of metastatic neuroendocrine tumors with fixed (90)Y-DOTATOC activity is useful and safe.
4